FDA Import Refusal 799-7575323-6/11/2 — Boehringer Ingelheim Canada
The FDA refused shipment 799-7575323-6/11/2 from Boehringer Ingelheim Canada (Canada) on Mar 11, 2022. The refused product falls under Drugs and Biologics — TELMISARTAN (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 11, 2022
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62ODC09 TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75